Exhibits dose- and time-dependent antiproliferative and pro-apoptotic effects through mitochondria/death receptor, MAPK, NF-κB, and HIF-1α signaling pathways; potential candidate for oral cancer chemotherapy [234]. The gene discussed is HIF1A; the disease is lip and oral cavity carcinoma.